AR025393A1 - Pildoras de desintegracion rapida basadas en quitosan - Google Patents

Pildoras de desintegracion rapida basadas en quitosan

Info

Publication number
AR025393A1
AR025393A1 ARP000104417A ARP000104417A AR025393A1 AR 025393 A1 AR025393 A1 AR 025393A1 AR P000104417 A ARP000104417 A AR P000104417A AR P000104417 A ARP000104417 A AR P000104417A AR 025393 A1 AR025393 A1 AR 025393A1
Authority
AR
Argentina
Prior art keywords
pills
chitosan
quitosan
rapid disintegration
based rapid
Prior art date
Application number
ARP000104417A
Other languages
English (en)
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of AR025393A1 publication Critical patent/AR025393A1/es

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2/00Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic
    • B01J2/02Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic by dividing the liquid material into drops, e.g. by spraying, and solidifying the drops
    • B01J2/06Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic by dividing the liquid material into drops, e.g. by spraying, and solidifying the drops in a liquid medium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente se refiere a píldoras porosas de rápida desintegracion que contengan un principio activo, basadas en quitosán o un derivado alcalino delquitosán, obtenidas mediante un proceso de instilacion, consistente en instilar una solucion o dispersion acuosa de quitosán o un derivado alcalino delquitosán, uno o más principios activos, en su caso otras sustancias coadyuvantes, y un ácido, en un líquido refrigerante a una temperatura máxima de -5°C paraque la solucion o dispersion se solidifiqueen formas de gotas; aislar las gotas o las píldoras solidificadas; y desecarlas. La invencion se refiere asimismo ala utilizacion de las píldoras para la elaboracion de un medicamento o una sustancia de diagnostico.
ARP000104417A 1999-08-27 2000-08-25 Pildoras de desintegracion rapida basadas en quitosan AR025393A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19940795A DE19940795A1 (de) 1999-08-27 1999-08-27 Schnellzerfallende Pellets auf der Basis von Chitosan

Publications (1)

Publication Number Publication Date
AR025393A1 true AR025393A1 (es) 2002-11-27

Family

ID=7919872

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000104417A AR025393A1 (es) 1999-08-27 2000-08-25 Pildoras de desintegracion rapida basadas en quitosan

Country Status (26)

Country Link
US (1) US6770300B1 (es)
EP (1) EP1208140B1 (es)
JP (1) JP4944327B2 (es)
KR (1) KR100610176B1 (es)
CN (1) CN1208381C (es)
AR (1) AR025393A1 (es)
AT (1) ATE331755T1 (es)
AU (1) AU768328B2 (es)
BR (1) BR0013562A (es)
CA (1) CA2382902C (es)
CZ (1) CZ300123B6 (es)
DE (2) DE19940795A1 (es)
DK (1) DK1208140T3 (es)
ES (1) ES2267562T3 (es)
HK (1) HK1047122A1 (es)
HU (1) HUP0203079A3 (es)
IL (1) IL148221A (es)
MX (1) MXPA02002047A (es)
NZ (1) NZ517542A (es)
PL (1) PL203820B1 (es)
PT (1) PT1208140E (es)
RU (1) RU2248790C2 (es)
TR (1) TR200200519T2 (es)
TW (1) TW477697B (es)
WO (1) WO2001016218A1 (es)
ZA (1) ZA200201136B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE387487T1 (de) * 2003-05-23 2008-03-15 Procter & Gamble Waschmittelzusammensetzung zum gebrauch in einer textilwasch- oder geschirrspülmaschine
EP1627573A1 (en) * 2004-08-20 2006-02-22 Firmenich Sa A process for the incorporation of a flavor or fragrance ingredient or composition into a carbohydrate matrix
EP1993637A2 (en) * 2006-02-15 2008-11-26 Medingo Ltd. Systems and methods for sensing analyte and dispensing therapeutic fluid
WO2009153634A1 (en) 2008-06-19 2009-12-23 University Of Witwatersrand, Johannesburg A transmucosal delivery system
CA3107195C (en) 2009-11-02 2023-02-14 Mannkind Corporation Apparatus and method for cryogranulating a pharmaceutical composition
JP6392907B2 (ja) * 2016-04-14 2018-09-19 株式会社新菱 ガス含有基材およびその製造方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0081913B1 (en) * 1981-12-11 1985-06-26 JOHN WYETH & BROTHER LIMITED Process and apparatus for freezing a liquid medium
DE3711169A1 (de) 1987-04-02 1988-10-20 Messer Griesheim Gmbh Vorrichtung zum kontrollierten einfrieren von zaehfliessenden fluessigkeiten
JPH01152104A (ja) 1987-12-08 1989-06-14 Hokkaido Soda Kk 水溶性キトサン塩粉末の製造方法
ES2081384T3 (es) * 1990-04-25 1996-03-01 Hoechst Ag Preparado farmaceutico que contiene complejos de polielectrolitos en forma de microparticulas y por lo menos una sustancia activa.
DE4201172C1 (en) 1992-01-17 1993-07-22 Alfatec-Pharma Gmbh, 6900 Heidelberg, De Pellets contg. Aloe vera extract - useful, e.g. as antiinflammatory of antibiotic agents, or for treating gastric ulcers
DE4201173C2 (de) 1992-01-17 1998-10-29 Alfatec Pharma Gmbh Akutarzneimittel in Form von Dihydropyridinderivaten enthaltenden Pellets und ihre Herstellung
DE4201179A1 (de) * 1992-01-17 1993-07-22 Alfatec Pharma Gmbh Wirkstoff(e) enthaltendes granulat oder pellet mit einem geruest aus hydrophilen makromolekuelen und verfahren zu seiner herstellung
GB2311027B (en) * 1996-03-15 1999-10-27 Johnson & Johnson Medical Coated bioabsorbable beads for wound treatment
KR20000067855A (ko) * 1996-07-10 2000-11-25 웨스트 파머슈티컬 서비스 드러그 딜리버리 앤드 크리니컬 리써치 센터 리미티드 내피표적용 유전자치료제 전달시스템
WO1998003203A1 (fr) * 1996-07-19 1998-01-29 Yamanouchi Pharmaceutical Co., Ltd. Particules poreuses insolubles dans l'eau, constituees de substances biocompatibles et leur procede de production
US5976577A (en) * 1997-07-11 1999-11-02 Rp Scherer Corporation Process for preparing fast dispersing solid oral dosage form
DE19756314C2 (de) 1997-12-12 2000-06-29 Roland Bodmeier Zubereitung mit verlängerter Verweildauer am Applikationsort
DE19845246A1 (de) 1997-12-18 1999-06-24 Henkel Kgaa Vitaminhaltige Zubereitungen

Also Published As

Publication number Publication date
KR20020033774A (ko) 2002-05-07
DE19940795A1 (de) 2001-03-01
AU768328B2 (en) 2003-12-11
CN1370195A (zh) 2002-09-18
HUP0203079A3 (en) 2004-05-28
PL353890A1 (en) 2003-12-15
CZ300123B6 (cs) 2009-02-18
CA2382902C (en) 2009-02-03
US6770300B1 (en) 2004-08-03
EP1208140B1 (de) 2006-06-28
ES2267562T3 (es) 2007-03-16
HK1047122A1 (zh) 2003-02-07
BR0013562A (pt) 2002-07-16
JP4944327B2 (ja) 2012-05-30
EP1208140A1 (de) 2002-05-29
NZ517542A (en) 2003-06-30
PT1208140E (pt) 2006-11-30
JP2003508565A (ja) 2003-03-04
HUP0203079A2 (hu) 2003-01-28
DK1208140T3 (da) 2006-10-30
TW477697B (en) 2002-03-01
IL148221A (en) 2005-12-18
PL203820B1 (pl) 2009-11-30
DE50013092D1 (de) 2006-08-10
IL148221A0 (en) 2002-09-12
CN1208381C (zh) 2005-06-29
ZA200201136B (en) 2002-08-28
KR100610176B1 (ko) 2006-08-09
CZ2002654A3 (cs) 2002-07-17
CA2382902A1 (en) 2001-03-08
RU2248790C2 (ru) 2005-03-27
WO2001016218A1 (de) 2001-03-08
AU7275500A (en) 2001-03-26
TR200200519T2 (tr) 2002-06-21
MXPA02002047A (es) 2002-08-20
ATE331755T1 (de) 2006-07-15

Similar Documents

Publication Publication Date Title
UY27320A1 (es) Nuevas composiciones farmacéuticas
ES488168A0 (es) Proceso para la preparacion de tabletas farmaceuticas o medicinales de administracion oral, con liberacion retardada delagente activo, en tabletas en las que la cantidad de libera-cion del agente activo es predeterminada.
AR017512A1 (es) Tabletas de metilcelulosa rapidamente desintegrables para administracion por via oral y procedimiento para prepararlas
PE20010532A1 (es) FORMAS FARMACEUTICAS DE ADMINISTRACION ORAL AL MENOS PARCIALMENTE RETARDADAS CUYA SUSTANCIA ACTIVA FARMACEUTICA TRAMADOL SE ENCUENTRA AL MENOS PARCIALMENTE EN FORMA DE COMPUESTO FORMADO IN SITU CON UNA HIDROSOLUBILIDAD Menor o igual 100MG/ML, Y PROCE
CA2330330A1 (en) Pharmaceutical compositions comprising an amphoteric surfactant an alkoxylated cetyl alcohol and a polar drug
BR9503386A (pt) Formulaçao farmacêutica comprimido dispersivel e processo para a fabricaçao de comprimidos dispersíveis contendo cloridrato de fluoxetina
AR021922A1 (es) Formulaciones farmaceuticas en aerosol que contienen fluoroalcanos, budesonido y formoterol.
WO2009066146A3 (en) Stable solutions of sparingly soluble actives
WO2008035020A3 (fr) Forme galenique pour l'administration par voie trans-muqueuse de principes actifs
AR020392A1 (es) Formulaciones microencapsuladas.
WO2007005633A3 (en) Process for preparation of liquid dosage form containing sodium 4-phenylbutyrate
IS6511A (is) Lyfjaefnablöndur sem innihalda sykurfitusýru estera til að stýra losun á virkum innihaldsefnum
PT801559E (pt) Processo para a preparacao de formas de dosagem oral contendo um antibiotico de beta-lactama
AR027748A1 (es) Pequenas esferas o globulos que contienen estavudina y permiten la liberacion controlada de la misma
AR025393A1 (es) Pildoras de desintegracion rapida basadas en quitosan
NZ602441A (en) A fast dissolving pharmaceutical composition
BR9913782A (pt) Processo de preparação de uma formualação galênica que compreende fenofibrato como princìpio ativo, formulação galênica, medicamento e utilizações de um meio lìquido e de partìculas de fenofibrato
AR021921A1 (es) Formulaciones farmaceuticas en aerosol que contienen fluoroalcanos y budesonido.
WO2008087323A3 (fr) Forme galenique pour l'administration par voie trans-muqueuse de paracetamol
ECSP034915A (es) Formulacion farmaceutica de sabor enmascarado y procedimiento para su preparacion
UA100865C2 (ru) Твердый дисперсный продукт лекарственных средств на основе n-арилмочевины
PT1395231E (pt) Preparacao para a remocao de material queratinoso anormal
AR033896A1 (es) Preparaciones granuladas de gaboxadol.
UY26925A1 (es) Sistemas saborizantes para composiciones farmacéuticas y métodos para hacer dichas composiciones
ES2194899T3 (es) Composicion farmaceutica para administracion transdermica sistemica del principio activo morfina-6-glucuronido.

Legal Events

Date Code Title Description
FB Suspension of granting procedure
FC Refusal